Assessment of corticosteroid (CS)-associated adverse events (AEs) with long-term (LT) exposure to low-dose prednisone (P) given with abiraterone acetate (AA) to metastatic castration-resistant prostate cancer (mCRPC) patients (Pts) Meeting Abstract


Authors: Fizazi, K.; Chi, K. N.; de Bono, J. S.; Gomella, L. G.; Miller, K.; Rathkopf, D. E.; Ryan, C. J.; Scher, H. I.; Shore, N. D.; De Porre, P.; Londhe, A.; McGowan, T.; Pehlivanov, N.; Charnas, R. L.; Todd, M. B.; Montgomery, R. B.
Abstract Title: Assessment of corticosteroid (CS)-associated adverse events (AEs) with long-term (LT) exposure to low-dose prednisone (P) given with abiraterone acetate (AA) to metastatic castration-resistant prostate cancer (mCRPC) patients (Pts)
Meeting Title: 2015 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 7 Suppl.
Meeting Dates: 2015 Feb 26-28
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-03-01
Language: English
ACCESSION: WOS:000356886700171
PROVIDER: wos
DOI: 10.1200/jco.2015.33.7_suppl.169
Notes: Meeting Abstract: 169 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    272 Rathkopf
  2. Howard Scher
    1130 Scher